IP

This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

4 results for: life sciences corporate services

Federal Circuit: Conventional Techniques Do Not Bar Patent Eligibility

3/5/2026 9:20:00 PM

Federal Circuit: Conventional Techniques Do Not Bar Patent Eligibility

By Womble Bond Dickinson Seiko Okada B. Logan Buck

In REGENXBIO v. Sarepta Therapeutics, the Federal Circuit recently held that a cell containing a non-naturally occurring recombinant...

Actualizing Therapy from Psychedelic Compounds Requires Acknowledging the Past Pioneers as well as Encouraging Cooperation from Current Market Players

11/20/2025 8:23:00 PM

Actualizing Therapy from Psychedelic Compounds Requires Acknowledging the Past Pioneers as well as Encouraging Cooperation from Current Market Players

By Ben Bourke

An audio summary of this article is available in the player below. Scroll to keep reading. Listen and subscribe to Womble Perspectives...

Unsettling Expectations: Avoiding Discretionary Denial of IPR Petitions

9/9/2025 7:28:00 PM

Unsettling Expectations: Avoiding Discretionary Denial of IPR Petitions

By Evan Boetticher

USPTO Acting Director Coke Stewart's introduction of settled expectations into the discretionary denial calculus for inter partes review...

Developments in Patent Subject Matter Eligibility for Software-Related Inventions, in View of Guvera v. Spotify

5/5/2025 4:24:00 PM

Developments in Patent Subject Matter Eligibility for Software-Related Inventions, in View of Guvera v. Spotify

By Kurt Prange

This article is a revised and updated version of an earlier article titled “Patent Protection for Entertainment Software Inventions”...